CLVS
Clovis Oncology Inc
$0.08
Earnings Summary
Revenue | $30.66Mn |
Net Profits | $-56.01Mn |
Net Profit Margins | -182.68% |
Highlights
Clovis Oncology Inc’s revenue fell -19.13% since last year same period to $30.66Mn in the Q3 2022. On a quarterly growth basis, Clovis Oncology Inc has generated -4.6% fall in its revenue since last 3-months.
Clovis Oncology Inc’s net profit jumped 16.91% since last year same period to $-56.01Mn in the Q3 2022. On a quarterly growth basis, Clovis Oncology Inc has generated 21.47% jump in its net profits since last 3-months.
Clovis Oncology Inc’s net profit margin fell -2.75% since last year same period to -182.68% in the Q3 2022. On a quarterly growth basis, Clovis Oncology Inc has generated 17.68% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Clovis Oncology Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.37 |
EPS Estimate Current Year | -0.37 |
Highlights
Clovis Oncology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.37 - a 9.76% jump from last quarter’s estimates.
Clovis Oncology Inc’s earning per share (EPS) estimates for the current year stand at -0.37.
Key Ratios
Key ratios of the Clovis Oncology Inc post its Q3 2022 earnings
Earning Per Share (EPS) | -0.39 |
Highlights
Clovis Oncology Inc’s earning per share (EPS) jumped 30.36% since last year same period to -0.39 in the Q3 2022. This indicates that the Clovis Oncology Inc has generated 30.36% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-05-05 | -0.43 | -0.44 | -2.33% |
2022-08-08 | -0.41 | -0.5 | -21.95% |
2022-11-09 | -0.41 | -0.39 | 4.88% |
₹0 US Stocks a/c Opening Fee